Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of MacroGenics, Inc. (NASDAQ: MGNX).
September 24, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MGNX
12:00pm, Wednesday, 07'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:40am, Wednesday, 07'th Aug 2024
LOS ANGELES, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. (“MacroGenic
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc. (MGNX)
09:30am, Wednesday, 07'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky
02:20am, Wednesday, 07'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
Compared to Estimates, MacroGenics (MGNX) Q2 Earnings: A Look at Key Metrics
10:30pm, Tuesday, 06'th Aug 2024
The headline numbers for MacroGenics (MGNX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Shareholders that lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX
09:40pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
MacroGenics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGNX
09:30pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
Investors who lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX
08:30pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
06:32pm, Tuesday, 06'th Aug 2024
MacroGenics (MGNX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.36 per share a year ago.
Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky
06:00pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, f
MGNX Investors Have Opportunity To Lead MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm
05:45pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. ("MacroGenics
MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
04:01pm, Tuesday, 06'th Aug 2024
ROCKVILLE, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibod
MGNX Investors Have Opportunity To Lead MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm
04:00pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. ("MacroGenics
